Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

Sponsor
Novo Nordisk A/S
Study ID
NCT02255266
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This study is conducted in Europe. The aim of this study is to investigate Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in daily Practice.

Key Dates

Start date
Mar 26, 2015
Status verified
Apr 2018
Primary completion
Nov 16, 2015
Completion
Nov 16, 2015

Study Design

Enrollment
1,788 participants (actual)

Arms

  • Arm: A

Primary Outcome Measure

Frequency of patients achieving HbA1c reduction of at least 1%-point [ Time Frame: Week 0, week 52 ]

Related Studies